ORIGINAL ARTICLE

Case report: a 33-year-old man with recurrent ureteropelvic junction obstruction

Yohanes Dona Christi Utama , Dimas S. Wibisono, Angga Riskiawan

Yohanes Dona Christi Utama
General Practitioner – ST. Elisabeth Hospital Semarang, Indonesia. Email: [email protected]

Dimas S. Wibisono
Urology Specialist – Medical Faculty of Diponegoro University & Urology Department of ST. Elisabeth Hospital Semarang, Indonesia

Angga Riskiawan
Medical Faculty, Universitas Diponegoro, Semarang, Indonesia
Online First: February 02, 2020 | Cite this Article
Utama, Y., Wibisono, D., Riskiawan, A. 2020. Case report: a 33-year-old man with recurrent ureteropelvic junction obstruction. Bali Medical Journal 9(1): 62-66. DOI:10.15562/bmj.v9i1.1657


Introduction: Ureteropelvic Junction Obstruction (UPJO) is the obstruction of upper urinary tract, present in fetal life until adulthood. Congenital UPJO mostly results from an intrinsic process with dilatation of renal collecting system. Acquired UPJO in adulthood may present without dilatation of renal collecting system, correlated with urolithiasis, infection, postoperative peripyelo-inflammatory fibrotic complication, and urothelial malignancy. In the past, Pyeloplasty, classic dismembered (Anderson-Hynes) or laparoscopic, is the gold standard treatment. In this study we would like to report and discuss comprehensive etiologies, diagnostic, and its treatment based from real case.

Case Presentation: We report case: a 33-year-old Indonesian man with left flank colic pain (VAS:8/10), nausea, and hematuria that did not disappear with medication. He had stone history in right proximal ureter with hydronephrosis and hydroureter, Ureterorenoscopy had been performed two years ago. Other vital signs and hemodynamics were stable. Abdominal USG demonstrated bilateral hydronephrosis and hydroureter. Abdominal X-Ray showed right ureter stone. Right-Left Ureterorenoscopy + Double-J-Stent were performed. The diagnosis was Bilateral Nephrolithiasis, Stenosis, and Proximal Ureter Obstruction leading to Recurrent UPJO. Three months later there was still pain, the patient was undergone Cystoscopy + URS + Laser Endopyelotomy + DJ-Stent Replacement (from 6 to 7 Fr). One month later, DJ-stents were removed but the stenotic ureter remained so Laparoscopic End-to-End Proximal Ureter Anastomosis Resection and DJ-stent Insertion were finally performed. Patient’s complaints were slightly reduced.

Conclusion: The Recurrent UPJO cause inadequate urinary flow leading to renal impairment. Clinical signs, symptoms, etiologies, and diagnostic imaging have significant role in determining the diagnosis. Early surgical intervention is the definitive treatment to reduce renal damage and its complications. Further researches to establish the causes, clinical manifestations, diagnostic imagings, and alternative treatments of UPJO are highly expected.

References

Whitaker RH. Clinical assessment of pelvic and ureteral function. Urology. 1978;12:146–150.

Kausik Sankar, Segura Joseph W. Surgical management of ureteropelvic junction obstruction in adults. Int Braz J Urol. 2003;29:3-10

Alberti, C. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution. European Review for Medical and Pharmacological Sciences. 2012;16:21-28.

McAninch J, Lue T. Smith & Tanagho’s general urology: 18th edition. USA: Mc Graw Hill Lange medical book; 2013. p. 575.

Han SW, Lee SE, Kim JH, Jeong HI, Rha KH, Choi SK. Does delayed operation for pediatric ureteropelvic junction obstruction cause histopathological changes? J Urol. 1998;160:984-988.

Klein J, Gonzalez J, Miravete M, Caubet C, Chaaya R, Decramer S, et al. Congenital uretero-pelvic junction obstruction: human disease and animal models. Int J Exp Pathol. 2011;92:168-192.

Zhang P, Peters CA, Rosen S. Ureteropelvic junction obstruction: morphological and clinical studies. Pediatr Nephrol. 2000;14:820-826.

Wein, Alan J. (editor-in-chief), et al. Campbell-Walsh urology: eleventh edition. Philadelphia: Elsevier; 2016. p. 1104.

Abraham GP, Siddaiah AT, Ramaswami K, George D, Das K. Laparoscopic management of recurrent uretero pelvic junction obstruction following pyeloplasty. Urol Ann. 2015;7:183-7.

Subhasis KG, Declan M, Anthony JC, Daniel AM. Laparoscopic pyeloplasty outcomes of elderly patients. Journal of endourology. 2011;25:251-256.

Moon DA, El-Shazly, Chang CM, et al. Laparoscopic pyeloplasty: Evolution of a new gold standard. Urology. 2006;67:932–936.

El-Shazly MA, Moon DA, Eden CG. Laparoscopic pyeloplasty: Status and review of literature. J Endourol. 2007;21:673–678.

Symons SJ, Bhirud PS, Jain V, et al. Laparoscopic pyeloplasty: Our new gold standard. J Endourol. 2009;23:463–467.

Hamm FC, Weinberg SR, Waterhouse RK. End-to-end ureteral anastomosis: An original technique. The journal of urology. 1962;87:12-18.

Vargas CV, Garcia CA, Ruiz HC, Moreno RMM, Escassi GA, Garrido PJI, Paredes ERM. Structural alterations of the smooth muscle and the EGFR expression and C-kit in congenital pyeloureteral stenosis: Relationship with the pathogenesis. Cir Pediatr. 2010;23:82-87.

Park JM, Bloom DA. The pathophysiology of UPJ obstruction. Urol Clin North Am. 1998;25:161-169.

Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75:1145-1152.

Dal CA, Stanziale R, Corradi A, Andreucci VE, Migone L. Effects of acute ureteral obstruction on glomerular hemodynamics in rat kidney. Kidney Int. 1977;12:403-411.

Stratta P, Canavese C, Dogliani M, Mazzucco G, Monga G, Vercellone A. The role of free radicals in the progression of renal disease. Am J Kidney Dis. 1991;5:31-37.

Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell. 2007;31:1-12.

Docherty N, O’Sullivan O, Healy D, Fitzpatrick J, Watson W. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol. 2006;290:4-13.

Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 1990;11: 97-101.

Yang Y, Hou Y, Wang CL, Ji SJ. Renal expression of epidermal growth factor and transforming growth factor-beta 1 in children with congenital hydronephrosis. Urology. 2006;67:817-821.

Taha MA, Shokeir AA, Osman HG, El-aziz ABD, Ael A, Farahat. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Urology. 2007;69:560-565.

Furness PD, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factor-beta 1 correlates with upper urinary tract obstruction in children. J Urol. 1999;162:1033-1036.

Decramer S, Bascands JL, Schanstra JP. Non-invasive markers of ureteropelvic junction obstruction. World J Urol. 2007;25:457-465.

Thornhill BA, Forbes MS, Coleman CM, Marcinko ES, Liaw L, Chevalier RL. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int. 2005;70: 1735-1741.

Vallés P, Manucha W. H+-ATPase activity on unilateral ureteral obstruction: interactions of endogenous nitric oxide and angiotensin-2. Kidney Int. 2000;58:1641-1651.

Ito K, Chen J, Asano T, Vaughan EDJ, Poppas DP, Hayakawa M, Felsen D. Liposome-mediated gene therapy in the kidney. Hum Cell. 2004;17:17-28.

Zaccara A, Marchetti P, La sala E, Caione P, De gennaro M. Are preoperative parameters of unilateral pyelo-ureteric junction obstruction in children predictive of postoperative function improvement? Scand J Urol Nephrol. 2000;34:165-168.

Degrazia E, Castagnetti M, Cimador M. Surgical or conservative treatment of congenital hydronephrosis: ten years’ experience. Minerva Pediatr. 2001;51:275-279.

Koff SA. Neonatal management of unilateral hydronephrosis. Urol Clin North Am. 1998;25:181-186.

Karavida N, Basu S, Grammaticos P. Furosemide for the diagnosis of complete or partial ureteropelvic junction obstruction. Hell J Nucl Med. 2010;13:11-14.

Roarke MC, Sandler C. Provocative imaging: diuretic renography.Urol Clin North Am. 1998;25:227-249.

Desai MM, Desai MR, Gill IS. Endopyeloplasty versus endopyelotomy versus laparoscopic pyeloplasty for primary ureteropelvic junction obstruction. Urology. 2004;64:16–21.

Canes D, Berger A, Gettman MT, Desai MM. Minimally invasive approaches to ureteropelvic junction obstruction. Urol Clin North Am. 2008;35:425–439.

Janetschek G, Peschel R, Altarac S, Bartsch G. Laparoscopic and retroperitoneoscopic repair of ureteropelvic junction obstruction. Urology. 1996;47:311–316.

Braga LH, Lorenzo AJ, Skeldon S, Dave S, Bagli DJ, Khoury AE, et al. Failed pyeloplasty in children: Comparative analysis of retrograde endopyelotomy versus redo pyeloplasty. J Urol. 2007;178:2571‑5.

Veenboer PW, Chrzan R, Dik P, Klijn AJ, de Jong TP. Secondary endoscopic pyelotomy in children with failed pyeloplasty. Urology. 2011;77:1450‑4.

Jabbour ME, Goldfischer ER, Klima WJ, Stravodimos KG, Smith AD. Endopyelotomy after failed pyeloplasty: The long‑term results. J Urol. 1998;160:690‑2.

Preminger GM, Clayman RV, Nakada SY, Babayan RK, Albala DM, Fuchs GJ, et al. A multicenter clinical trial investigating the use of a fluoroscopically controlled cutting balloon catheter for the management of ureteral and ureteropelvic junction obstruction. J Urol. 1997;157:1625‑9.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0